Calibre What Science Can Do

This website contains promotional content about AstraZeneca Medications. This website is intended for healthcare professionals involved in the Acute Coronary Syndrome care pathway, such as hospital specialists from cardiology and cardiology-related departments, including A&E and elderly care, as well as GPs with a specific interest in cardiology, nurses, pharmacists and payers with budget responsibilities in cardiology.

Expert Opinion

The PRECLUDE study
Prof. Stefan James

Stefan K James MD, PhD

Professor of Cardiology, Dept. of Medical Sciences, Scientific Director UCR, Uppsala University, Uppsala, Sweden

Stefan James is Professor of Cardiology at Uppsala University and Scientific Director of Uppsala Clinical Research Center. He is a Senior Interventional Cardiologist at Uppsala University Hospital Sweden. He graduated from Uppsala University Medical School and completed specialist training in Uppsala. He has previously held positions at the Karolinska Hospital, the University Hospital Örebro and Duke Clinical Research Institute, Duke University.

A Fellow of the European Society of Cardiology (ESC), Professor James is the Society’s official representative for the European Commission for Evaluation of Medical Devices. He co-chaired the previous and current 2017 ESC task force group for ST-elevation myocardial infarction, co-author of several of the recent European guidelines on ACS and revascularization.

Stefan James served as PI on steering committees for numerous international trials in cardiology including PLATO, Early-ACS trial, EVOLUTION, APPRAISE II, GUSTO IV-ACS, GEMINI and THEMIS. He is the chairman of the Swedish Coronary and Angioplasty registry and a member of the steering committee of SWEDEHEART and the Swedish TAVI registry. He has pioneered the concept of registry based randomized clinical trials and served as the study chair for large outcome trials TASTE and VALIDATE. His research has been published in over 200 peer-reviewed cardiology journals, and he is an editorial board member for the European Heart Journal, Circulation and American Heart Journal. Last year, he was named by Thomson Reuters as a ‘Highly Cited Researcher’, ranking him among the top 1% most cited in clinical medicine.